Shaping Treatment Expectation to Optimize Efficacy of Interleukin 17A Antagonist Secukinumab in Psoriasis Patients

Stefanie Hölsken,1 Frederik Krefting,2 Senta Mühlhaus,2 Daniela Bese,2 Manfred Schedlowski,1,3 Wiebke Sondermann2 1Institute of Medical Psychology and Behavioral Immunobiology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany; 2Department of Dermatology, Venereology and Allerg...

Descrición completa

Detalles Bibliográficos

Principais autores:	Hölsken S, Krefting F, Mühlhaus S, Bese D, Schedlowski M, Sondermann W
Formato:	Artigo
Idioma:	Inglês
Publicado:	Dove Medical Press 2025-01-01
Series:	Psoriasis: Targets and Therapy
Assuntos:	psoriasis treatment psychodermatology placebo effect
Acceso en liña:	https://www.dovepress.com/shaping-treatment-expectation-to-optimize-efficacy-of-interleukin-17a--peer-reviewed-fulltext-article-PTT
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!